Newborn screening for lysosomal acid lipase deficiency — the addition of LAL enzyme activity or LIPA gene analysis to state-mandated newborn screening panels, enabling presymptomatic diagnosis and treatment initiation within days of birth — represents the fastest-expanding public health intervention in the global acid lipase deficiency landscape, with the Acid Lipase Deficiency...